Zyla Life Sciences Proceeds from Convertible Debt
Zyla Life Sciences reported Proceeds from Convertible Debt of -$1.53 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2019-03-29
- Zyla Life Sciences proceeds from convertible debt for the quarter ending 2015-09-30 was $0.00.
- Zyla Life Sciences proceeds from convertible debt for the quarter ending 2015-06-30 was $56.71M.
- Zyla Life Sciences proceeds from convertible debt for the quarter ending 2015-03-31 was $14.78M.
- Zyla Life Sciences proceeds from convertible debt for the quarter ending 2013-12-31 was $0.00.
- Zyla Life Sciences proceeds from convertible debt for fiscal 2017 was -$1.53M.
- Zyla Life Sciences proceeds from convertible debt for fiscal 2013 was $15.00M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$1.53M 10-K · filed 2019-03-29 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $56.71M derived: sum of 2 quarters · filed 2015-11-06 | $71.50M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $56.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $71.50M 10-Q · filed 2015-08-07 | ||
| 2015-03-31 | $14.78M 10-Q · filed 2015-05-08 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $10.00M derived: sum of 2 quarters · filed 2015-03-16 | $15.00M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $15.00M 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $5.00M 10-Q · filed 2014-08-14 |